M. E. Cakmak Et Al. , "Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results," European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI) , vol.75, London, Canada, pp.371, 2020
Cakmak, M. E. Et Al. 2020. Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results. European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI) , (London, Canada), 371.
Cakmak, M. E., Kaya, S. B., Bostan, C. O., Celebioglu, E., Karakaya, G., & Kalyoncu, A. F., (2020). Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results . European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI) (pp.371). London, Canada
Cakmak, M. Et Al. "Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results," European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI), London, Canada, 2020
Cakmak, M. E. Et Al. "Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results." European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI) , London, Canada, pp.371, 2020
Cakmak, M. E. Et Al. (2020) . "Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results." European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI) , London, Canada, p.371.
@conferencepaper{conferencepaper, author={M. E. Cakmak Et Al. }, title={Aspirin desensitization and regular treatment with 300 mg aspirin in patients with N-ERD: 12-year results}, congress name={European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI)}, city={London}, country={Canada}, year={2020}, pages={371} }